Skip to Main Content

Paper Details

Co-overexpression of AXL and c-ABL predicts a poor prognosis in esophageal adenocarcinoma and promotes cancer cell survival.
J Cancer
2
2020
Author NameAffiliation
Sharon PhillipsVanderbilt Center for Quantitative Sciences, Vanderbilt University Medical Center
Mary Kay WashingtonVanderbilt University Medical Center
  • 1 - 2

Datasets